Abstract

The effective treatment of cervical intraepithelial neoplasia (CIN) can prevent cervical cancer. Salvia miltiorrhiza is a medicinal and health-promoting plant. To identify a potential treatment for CIN, the effect of S. miltiorrhiza extract and its active components on immortalized cervical epithelial cells was studied in vitro. The H8 cell was used as a CIN model. We found that S. miltiorrhiza extract effectively inhibited H8 cells through the CCK8 method. An HPLC–MS analysis revealed that S. miltiorrhiza extract contained salvianolic acid H, salvianolic acid A, salvianolic acid B, monomethyl lithospermate, 9‴-methyl lithospermate B, and 9‴-methyl lithospermate B/isomer. Salvianolic acid A had the best inhibitory effect on H8 cells with an IC50 value of 5.74 ± 0.63 μM. We also found that the combination of salvianolic acid A and oxysophoridine had a synergistic inhibitory effect on H8 cells at molar ratios of 4:1, 2:1, 1:1, 1:2, and 1:4, with salvianolic acid A/oxysophoridine = 1:2 having the best synergistic effect. Using Hoechst33342, flow cytometry, and Western blotting analysis, we found that the combination of salvianolic acid A and oxysophoridine can induce programmed apoptosis of H8 cells and block the cell cycle in the G2/M phase, which was correlated with decreased cyclinB1 and CDK1 protein levels. In conclusion, S. miltiorrhiza extract can inhibit the growth of H8 cells, and the combination of salvianolic acid A (its active component) and oxysophoridine has a synergistic inhibitory effect on H8 cells and may be a potential treatment for cervical intraepithelial neoplasia.

Highlights

  • Cervical cancer is the fourth most common malignant tumor in women worldwide, with 530,000 new cases and 270,000 deaths every year [1]

  • We found that OSR effectively inhibited the proliferation of H8 cells and that Salvianolic acid A (SAA) and OSR exerted synergistic effects on H8 cells

  • We studied the extract of S. miltiorrhiza to ideneffects of S. miltiorrhiza extract (SME) and its active components on H8 cells were determined using the CCK8 tify its effective components for treating cervical intraepithelial neoplasia

Read more

Summary

Introduction

Cervical cancer is the fourth most common malignant tumor in women worldwide, with 530,000 new cases and 270,000 deaths every year [1]. The main methods of managing cervical cancer are prevention via the HPV vaccine before disease diagnosis and surgical treatment after diagnosis [2]. The application of the HPV vaccine in nondeveloped countries has not been popularized [3,4]. Surgical resections after the diagnosis of the disease cause permanent damage to the human body [5,6]. The progression of the HPV infection to cervical cancer takes decades. During this process, cervical intraepithelial neoplasia (CIN) always occurs, which is equivalent to the clinical “precancerous” stage [2,7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call